APA (7th ed.) Citation

Michaeli, D., & Michaeli, C. T. (2025). Value-based indication-specific pricing and weighted-average pricing: Estimated price and cost savings for cancer drugs. PharmacoEconomics, 43(4), . https://doi.org/10.1007/s40273-024-01448-x

Chicago Style (17th ed.) Citation

Michaeli, Daniel, and Christoph T. Michaeli. "Value-based Indication-specific Pricing and Weighted-average Pricing: Estimated Price and Cost Savings for Cancer Drugs." PharmacoEconomics 43, no. 4 (2025). https://doi.org/10.1007/s40273-024-01448-x.

MLA (9th ed.) Citation

Michaeli, Daniel, and Christoph T. Michaeli. "Value-based Indication-specific Pricing and Weighted-average Pricing: Estimated Price and Cost Savings for Cancer Drugs." PharmacoEconomics, vol. 43, no. 4, 2025, https://doi.org/10.1007/s40273-024-01448-x.